B. Braun Medical’s renal therapies division has announced the availability of the Plasmat Futura System for heparin-induced extracorporeal lipoprotein precipitation (HELP) LDL Apheresis therapy. HELP ...
Bendamustine treatment before apheresis is known to reduce survival in large B-cell lymphoma (LBCL) patients receiving chimeric antigen receptor (CAR) T-cell therapy. Bendamustine has been shown to ...
KHON Honolulu on MSN
Hyundai Hope on Wheels donates to advance cancer treatment and research
The Kapi'olani Medical Center for Women & Children received a $160,000 donation from a local Hyundai dealership to help them ...
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, ...
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial The study included CAR T-cell ...
When Michael Linenberger, MD, retires from Fred Hutchinson Cancer Center at the end of 2022, his legacy will be felt by coworkers, trainees, patients and their families long after he has left the ...
Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...
NEWARK, Del, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The global Therapeutic Apheresis Market is poised for a CAGR of 6.8% over the forecast period. With a projected value of US$ 2,717.9 million in 2023, the ...
Calendar year 2020 will be remembered for the COVID-19 pandemic, handwashing, and social distancing. As I write this, clinical trials are underway to test both therapeutics and vaccine candidates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback